Empower Advisory Group LLC reduced its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 6.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 163,309 shares of the company's stock after selling 10,489 shares during the quarter. Empower Advisory Group LLC's holdings in Colgate-Palmolive were worth $14,846,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the fourth quarter worth about $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $36,000. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Roxbury Financial LLC bought a new position in Colgate-Palmolive during the 4th quarter worth $43,000. Finally, Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the third quarter worth $53,000. 80.41% of the stock is owned by institutional investors and hedge funds.
Several brokerages have recently issued reports on CL. Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Raymond James reissued an "outperform" rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. UBS Group dropped their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of "Hold" and a consensus price target of $101.16.
Read Our Latest Research Report on CL
NYSE CL opened at $86.10 on Tuesday. Colgate-Palmolive has a 12 month low of $83.20 and a 12 month high of $109.30. The company has a market capitalization of $70.34 billion, a P/E ratio of 24.46, a PEG ratio of 4.12 and a beta of 0.44. The company's 50 day simple moving average is $89.53 and its 200 day simple moving average is $96.33. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is 56.82%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.